Titan Pharmaceuticals, Inc.
(NASDAQ CM: TTNP)
Rigrodsky Law, P.A. is investigating Titan Pharmaceuticals, Inc. (“Titan”) regarding possible breaches of fiduciary duties and other violations of law related to Titan’s agreement to merge with KE Sdn. Bhd.